Psychiatrists in Spain ADHD experts present new projects for the treatment of this disorder in children and adults.

Psychiatrists Spanish experts in ADHD (Hyperactivity Disorder and Attention Deficit) present new projects for the treatment of this disorder in children and adults

• The Central Nervous System Unit of the Spanish laboratory Juste organized a reunion with the best specialists in child psychiatry of the main national focal points (Fundación Hospital de Alcorcón Madrid, Hospital Clínico Universitario de Zaragoza, Hospital Clínico de Barcelona, University Hospital Vall d'Hebron ... to support new initiatives in dealing with patients suffering from ADHD and a new International Directory of research protocols and clinical treatment of this condition.

• Psychiatrists maintain that ADHD is a disease and clinical chemistry where there is a change in the production of neurotransmitters, primarily dopamine and noreadrenalina, and therefore should be treated pharmacologically and, subsequently, with a multidisciplinary psychological, psychoeducational and family to help patients who suffer from ADHD children and also adults.

• The child psychiatrists maintain that this disease affects between 8 and 10% of children and 5% of the adult population. However, only 1% of children are diagnosed and properly treated to improve their quality of life.

• These experts argue that many emerging Patients Associations in this condition because the Administration does not support or to patients or physicians. Proof of this is that there are no associations of patients with appendicitis, identifies these psychiatrists.



From left to right: Xavier Gastaminza, Psychiatrist, Hospital Universitario Vall d'Hebron; Ayats Arturo Perez, Director of the Division of Central Nervous System and Laboratory Juste Montañés Francisco, Chief of Psychiatry at the Hospital Fundación de Alcorcón, Madrid.

Unity of Central Nervous System Laboratory Spanish Juste has convened today in Madrid at the best experts in infant-juvenile psychiatry Spanish representatives of major hospitals in order to bring new and better treatment of and approach to the treatment of patients suffering Disorder and Attention Deficit Hyperactivity Disorder (ADHD) in children as in adults, affecting about 7% of children and 5% of the adult population according to WHO.

Among this panel highlights the presence of psychiatrists Alcorcón Hospital Foundation, the Hospital Clinic of Barcelona and the Hospital Universitario Vall d'Hebron.

According to these medical experts have stated, the average time it takes for a child to receive a correct diagnosis is too long and this disease is underdiagnosed in our country. "Specifically in Spain, it takes seven years to diagnose this disease compared to other European countries, eg UK, where it takes months to diagnose this disease," and adds, "only a further 1% of all Spanish population that suffers from this disorder is diagnosed and properly treated, "says Dr. Francisco Montañés, Chief of Psychiatry at the Hospital de Alcorcón.

These experts are calling for more aid and support from local authorities of each community and, especially, by the Ministry of Health. "Psychiatry is a specialty that has sufficient support from the government. ADHD is a disease that has a 80% inheritance. This means that the child psychiatric parents are trying to - adults with this disorder-and their children who also have this genetically inherited disease. This means that now we are without resources and totally collapsed in the treatment of this condition in Madrid, "says Dr. Francisco Montañés.

In fact, according to experts 50% of children with ADHD in the future will be people that if not properly treated will suffer from addictions to substances or have difficulties in their development work. "We found that 20% of adult patients who suffer from addictions to substances, really suffer with ADHD and a correct diagnosis can be solved his illness," says Dr. Montañés.

Dr. Xavier Gastaminza, Psychiatrist, Hospital Universitario Vall d'Hebron, supports these statements as more resources in infant-juvenile psychiatry can avoid spending a lot more in the future. "Patients Associations are emerging because we need help," says Xavier Gastaminza.

Due to the awareness that is having the knowledge of this disorder and there are websites like: http://www.hiperactividadmedicosypacientes.com "where patients' associations demanding more social support.

To respond to this social demand, the experts met today psychiatrists volunteered to perform various work projects. Have self GEITDAH acronyms mean Special Interest Group on ADHD. This panel aims to first, analyze all the international guidelines for diagnosis and treatment of this condition and subsequently made a guide for Spanish protocol, research and national treatment to serve as a reference for all of Europe.

Secondly, have been divided into two panels: the first group will analyze the results of drugs in the treatment of this condition and the second group of psychiatrists, analyze and report the findings of non-pharmacological treatments.

In this line psychiatrists agree that the methylphenidate extended release over 62 clinical trials worldwide has proved to be the best medicine star has appeared in these patients. "Spain has come a long way from the pharmacological point of view, as was recently launched Medikinet, a drug that takes effect during eight hours, the time for a fair day's work. There was a void in the market because until now the formulas and did indeed too long or too short time. Now we have formulas galenical balanced, "explains Dr. Montañés.

This group is coordinated by Dr. Francisco Montañes Rada, Head of Child Psychiatry and Dr. Xavier Alcorcón Gastaminza, Psychiatrist, Hospital Universitario Vall d'Hebron.

These experts want to share with the public that ADHD is a disease with a biochemical origin involvement in the production of the neurotransmitter dopamine and essentially noreadrenalina. Therefore, there must be a first time since a correct diagnosis is essential to treat patients pharmacologically to standardize the production of these neurotransmitters is a disorder in which dopamine and noreadrenalina.

In the words of Dr. Francis Montañés more than 70% of patients treated with Medikinet have seen a marked improvement of their symptoms and improved their quality of life. "The long-acting methylphenidate is a dopamine blocker," says Dr. Montañés.

These experts insist that once patients are treated pharmacologically and focused on, and require a multidisciplinary psychoeducational support and generally throughout society.

Other projects that have raised these specialists is to develop, with the sponsorship of the Central Nervous System Unit of the laboratory-Juste an International Guide for ADHD treatment, and developing software for patient records for future research projects ADHD and creating informative websites for physicians and specialists.

Moreover, these specialists will develop an existing project to classify various subtypes of ADHD creating. This requires that these distinctions are complex because the disease has a very important variable for the life of a patient and thus reach conclusions in advance of this disease. "The creation of sub-subtypes and variants in this disease is very complex and we need computers to share information to help children and adults suffering from this disease. This is another of our objectives, "says Dr. Xavier Gastaminza.

Dr. Francisco Mountains has indicated that it intends to conduct a registry of patients by subgroups within the ADHD alternative for care to meet the needs of these patients and improve drug treatments in fair measure to advance knowledge and to help improve their quality of life.